Clinical trial
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00227565
Study timeline
Study start (unknown)2006-02-01Date precision: month
Registry last updated2016-07-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
pemetrexed disodiumDRUG · verified · RxNorm: pemetrexed disodium
radiationRADIATION
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Des MoinesIowa, United States7DenverColorado, United States6DaytonOhio, United States6PeoriaIllinois, United States5Green BayWisconsin, United States4Saint PaulMinnesota, United States3Sioux FallsSouth Dakota, United States3South BendIndiana, United States3DuluthMinnesota, United States3MinneapolisMinnesota, United States2Ann ArborMichigan, United States2SpartanburgSouth Carolina, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00227565 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.